Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma

Xiang Li, Rachel Kositsky, Anupama Reddy, Cassandra Love, Kikkeri Naresh, Jean L. Koff, Ilja Nystrand, Sirpa Leppä, Annika Pasanen, Marja Liisa Karjalainen-Lindsberg, Johannes Dunkel, Panu Kovanen, Qiu Qin, Govind Bhagat, Rebecca J. Leeman-Neill, Rashmi S. Goswami, Sarah Wildeman, Jan Delabie, Richard Burack, Andrew G. EvansCatalina Amador, Ji Yuan, Hina Naushad Qureishi, Shaoying Li, Jie Xu, C. Cameron Yin, Anne Ortved Gang, Peter H. Norgaard, Mette Pedersen, Jason Yongsheng Chan, Daryl Ming Zhe Cheah, Shin Yeu Ong, Chee Leong Cheng, Lianne Lee, Felik Paulua, Sarah L. Ondrejka, Eric D. Hsi, Magdalena Czader, Lin Wang, Amber Landis, Michael C. Churnetski, David L. Jaye, Christopher R. Flowers, Chad M. McCall, Jadee Neff, Matthew S. McKinney, Yuri Fedoriw, Eric Powers, Nathan D. Montgomery, Agata M. Bogusz, Andrea Stafford Hintz, Alexandra E. Kovach, Nishitha Reddy, Mary Ann Thompson Arildsen, Emily F. Mason, Ridas Juskevicius, William Choi, Rex Au-Yeung, Eric Tse, Vincent Sarno, Amy Chadburn, Rafael Lopez, Jennifer R. Chapman, Amir Behdad, Neta Goldschmidt, John Goodlad, Cathy Burton, Raju Pillai, Abner Louissaint, Dina Sameh Soliman, Razvan Panea, Tushar Dave, Barbara Xiong, Eileen Smith, Sandeep Dave

Research output: Contribution to journalArticle

Abstract

DISCLOSURES: Koff: Burroughs Wellcome Fund: Research Funding; V Foundation: Research Funding; Lymphoma Research Foundation: Research Funding; American Association for Cancer Research: Research Funding. Leppä:Roche: Honoraria, Research Funding; Takeda: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Bayer: Research Funding; Celgene: Membership on an entity's Board of Directors or advisory committees, Research Funding; Janssen-Cilag: Research Funding; Novartis: Membership on an entity's Board of Directors or advisory committees. Gang:ROCHE: Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees. Hsi:Abbvie: Research Funding; Eli Lilly: Research Funding; Cleveland Clinic&Abbvie Biotherapeutics Inc: Patents & Royalties: US8,603,477 B2; Jazz: Consultancy. Flowers:AbbVie: Consultancy, Research Funding; Denovo Biopharma: Consultancy; BeiGene: Consultancy, Research Funding; Burroughs Wellcome Fund: Research Funding; Eastern Cooperative Oncology Group: Research Funding; National Cancer Institute: Research Funding; V Foundation: Research Funding; Optimum Rx: Consultancy; Millenium/Takeda: Research Funding; TG Therapeutics: Research Funding; Gilead: Consultancy, Research Funding; Celgene: Consultancy, Research Funding; Karyopharm: Consultancy; AstraZeneca: Consultancy; Pharmacyclics/Janssen: Consultancy, Research Funding; Spectrum: Consultancy; Bayer: Consultancy; Acerta: Research Funding; Genentech, Inc./F. Hoffmann-La Roche Ltd: Consultancy, Research Funding. Neff:Enzyvant: Consultancy; EUSA Pharma: Honoraria, Membership on an entity's Board of Directors or advisory committees. Fedoriw:Alexion Pharmaceuticals: Other: Consultant and Speaker. Reddy:Genentech: Research Funding; BMS: Consultancy, Research Funding; Celgene: Consultancy; KITE Pharma: Consultancy; Abbvie: Consultancy. Mason:Sysmex: Honoraria. Behdad:Loxo-Bayer: Membership on an entity's Board of Directors or advisory committees; Thermo Fisher: Membership on an entity's Board of Directors or advisory committees; Pfizer: Other: Speaker. Burton:Bristol-Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees; Roche: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Travel; Celgene: Membership on an entity's Board of Directors or advisory committees; Takeda: Honoraria, Membership on an entity's Board of Directors or advisory committees. Dave:Data Driven Bioscience: Equity Ownership.

Original languageEnglish (US)
Number of pages1
JournalBlood
Volume134
Issue number1
DOIs
StatePublished - Nov 13 2019

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma'. Together they form a unique fingerprint.

  • Cite this

    Li, X., Kositsky, R., Reddy, A., Love, C., Naresh, K., Koff, J. L., Nystrand, I., Leppä, S., Pasanen, A., Karjalainen-Lindsberg, M. L., Dunkel, J., Kovanen, P., Qin, Q., Bhagat, G., Leeman-Neill, R. J., Goswami, R. S., Wildeman, S., Delabie, J., Burack, R., ... Dave, S. (2019). Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma. Blood, 134(1). https://doi.org/10.1182/blood-2019-130255